WinNonlin: steady state setup [Software]

posted by bobmarlo – 2017-01-17 21:36 (3086 d 00:48 ago) – Posting: # 16968
Views: 12,510

Dear Helmut,
Thank you for your response. Your simulation and explanation makes complete sense to me. However, I am still curious about calculation of CL and MRT. As CL=Dose/AUC and MRT=(AUMC/AUC) - (Duration of Infusion/2). These parameters are dependent on AUC & AUMC. And the problem with AUC & AUMC I see is that baseline being 10, the calculated AUC is sum of exposure due to second dose + exposure due to the baseline concentration of drug already present, which can contribute to as high as 10% of total AUC (200 at Cmax, 10 at 0h). In this situation do you think these parameters (CL and MRT) will still be good representative of Plasma PK for this drug? or there is way to analyze it better?
Thanks again to you and Mittyri for links.
Bob


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,679 registered users;
60 visitors (0 registered, 60 guests [including 11 identified bots]).
Forum time: 23:25 CEST (Europe/Vienna)

I think it is much more interesting to live with uncertainty
than to live with answers that might be wrong.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5